Ressources

Bienvenue dans notre banque interrogeable de ressources et de documentation sur l’approvisionnement plus sécuritaire et autres sujets connexes.

 

 
To inform future surveillance and research during the pandemic and other public health disasters, we report methods and lessons learned from an in-person survey of people who use opioids conducted by
Original research | 2022
Equity, About PWUD, Illegal drugs, Peer/PWLLE program involvement
Report | 2021
Policy/Regulatory, Decriminalization/legalization, Equity, Advocacy, Poverty, Illegal drugs
In this study, we wanted to examine the experience of overdose from the point of view of people who inject drugs.
Report | 2022
Overdose, Equity, About PWUD, Poverty, Illegal drugs, Indigenous, Stigma, Hospitals
Experiences of racial discrimination in the medical setting are common among Black patients and may be linked to mistrust in medical recommendations and poorer clinical outcomes.
Original research | 2022
Hesitancy of prescribers , Equity, About prescribers, Barriers and enablers
We aimed to understand how the presence of an addiction consultatoin service affected patients' and hospital-based providers' experiences with stigma in the hospital setting.
Original research | 2021
About prescribers, About PWUD, Stigma, Hospitals
This report summarizes the impact of overdoses and overdose-related loss on harm reduction workers and strategies to address their support needs.
Report | 2021
Overdose, Wrap-around services, Social services, Workplace
Person-centered analytical approaches (e.g., latent class analysis) provide a holistic understanding of individuals’ substance use patterns and help understand PSU heterogeneities among PWUO and their
Lit review | 2022
About PWUD, Housing, Legal system/law enforcement, Illegal drugs, Stimulants, Mental health
A scoping review was undertaken to identify the research on prescription drug monitoring programs published between January 2015 and April 2021.
Scoping review | 2022
Harm reduction, Policy/Regulatory, Safer supply, About prescribers, Substitution/OAT
Although medications to treat opioid use disorder (MOUD) are the standard of care during pregnancy, there are many potential gaps in the cascade of care for pregnant people experiencing incarceration.
Original research | 2022
About PWUD, Legal system/law enforcement, Substitution/OAT
Mutual-help groups (MHGs) are an integral component of the substance use disorder (SUD) treatment system in the U.S., and growing evidence suggests that they are effective and cost-effective for SUD-r
Original research | 2021
Wrap-around services, Equity, About PWUD, Poverty, Sex/Gender
To investigate the real-world effectiveness of pharmacological treatments (buprenorphine, methadone) of opioid use disorder (OUD).
Original research | 2022
Mortality, Harm reduction, About PWUD, Outcomes, Substitution/OAT
In the current study, we examined sex-based differences in psychiatric symptoms and relationships among sex, psychiatric symptoms, and opioid use outcomes in youth with OUD receiving buprenorphine/nal
Original research | 2022
About PWUD, Outcomes, Illegal drugs, Youth, Substitution/OAT, Sex/Gender , Mental health

To determine the efficacy of topiramate vs placebo as a treatment for cocaine dependence.

Original research | 2013
Stimulants, Substitution/OAT

Opioid use disorder (OUD) in pregnancy disproportionately impacts rural and American Indian (AI) communities.

Original research | 2021
About prescribers, Barriers and enablers, Indigenous, Rural/remote, Substitution/OAT, Sex/Gender , Parents/caregivers
Alcohol and other drug (AOD) workers from a variety of service settings are now frequently required to respond to methamphetamine users who are experiencing the harmful effects of methamphetamine, goi
Guide or handbook | 2008
Clinical guidance, Harm reduction, About prescribers, Social services, Illegal drugs, Stimulants, Transitions in care/treatment
Currently, three classes (opioid agonist, partial agonist-antagonist, and antagonist) of FDA-approved medications for opioid use disorder (MOUD) exist, yet few correctional settings offer any medicati
Original research | 2021
About PWUD, Legal system/law enforcement, Substitution/OAT, Stigma
We explore qualitative narratives of methamphetamine overdose and strategies used by people who use drugs to reduce the undesirable effects associated with methamphetamine use.
Original research | 2022
Overdose, Harm reduction, About PWUD, Illegal drugs, Stimulants
Little is known about knowledge and perceptions of fentanyl among people who are incarcerated.
Original research | 2022
Overdose, Harm reduction, Safer supply, About PWUD, Legal system/law enforcement, Illegal drugs, Substitution/OAT
Commentary | 2021
Advocacy, About PWUD, Illegal drugs, Workplace, Peer/PWLLE program involvement
While pharmacies have potential to be an easily accessible source of sterile syringes, research in cities has identified moral, legal and ethical barriers that preclude over-the-counter (OTC) sales to
Original research | 2022
Harm reduction, Hesitancy of prescribers , About pharmacists, Rural/remote, Stigma

Affiner votre recherche

Mots clés
Format
Région